Using Electronic Health Records to Derive Control Arms for Early Phase Single‐Arm Lung Cancer Trials: Proofȁ
![Shedding light on Digital Twin, Digital Patient, Virtual Patient and Synthetic Control Arm - InSilicoTrials Shedding light on Digital Twin, Digital Patient, Virtual Patient and Synthetic Control Arm - InSilicoTrials](https://insilicotrials.com/wp-content/uploads/2022/07/blog_size-915x515.png)
Shedding light on Digital Twin, Digital Patient, Virtual Patient and Synthetic Control Arm - InSilicoTrials
![soria on Twitter: "Antoine Yver believes that synthetic control arms can augment and enrich the debate around trials where randomization is not possible #FriendsAM18 https://t.co/qeWfZiaurP" / Twitter soria on Twitter: "Antoine Yver believes that synthetic control arms can augment and enrich the debate around trials where randomization is not possible #FriendsAM18 https://t.co/qeWfZiaurP" / Twitter](https://pbs.twimg.com/media/Dr5SHWIU0AAxl0g.jpg)
soria on Twitter: "Antoine Yver believes that synthetic control arms can augment and enrich the debate around trials where randomization is not possible #FriendsAM18 https://t.co/qeWfZiaurP" / Twitter
![Downloadable White Paper | Synthetic Control Arm® in Clinical Trials | Medidata Solutions - Medidata Solutions Downloadable White Paper | Synthetic Control Arm® in Clinical Trials | Medidata Solutions - Medidata Solutions](https://www.medidata.com/wp-content/uploads/2022/03/SCA-WP.png)
Downloadable White Paper | Synthetic Control Arm® in Clinical Trials | Medidata Solutions - Medidata Solutions
Synthetic and External Controls in Clinical Trials - A Primer for Researchers. - Document - Gale OneFile: Health and Medicine
![Historical clinical trials data can reduce the need for control arm patients | Medidata Solutions - Medidata Solutions Historical clinical trials data can reduce the need for control arm patients | Medidata Solutions - Medidata Solutions](https://www.medidata.com/wp-content/uploads/2019/05/Screen-Shot-2019-05-22-at-6.20.13-AM.png)
Historical clinical trials data can reduce the need for control arm patients | Medidata Solutions - Medidata Solutions
![Addressing challenges with real-world synthetic control arms to demonstrate the comparative effectiveness of Pralsetinib in non-small cell lung cancer | Nature Communications Addressing challenges with real-world synthetic control arms to demonstrate the comparative effectiveness of Pralsetinib in non-small cell lung cancer | Nature Communications](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41467-022-30908-1/MediaObjects/41467_2022_30908_Fig3_HTML.png)